PROK ProKidney Corp.
Healthcare$1.69-3.43%ClosedMarket Cap: $544.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.24
P/S
634.31
EV/EBITDA
-2.99
DCF Value
$0.88
FCF Yield
-26.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-224.4%
Operating Margin
-18959.7%
Net Margin
-8418.0%
ROE
7.4%
ROA
-25.6%
ROIC
-54.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $226.0K | -535.0% | $-44.9M | $-22.6M | $— | — |
| Q4 null | $225.0K | -544.0% | $-45.4M | $-19.2M | $— | — |
| FY null | $893.0K | 100.0% | $-165.0M | $-69.0M | $— | — |
| Q3 null | $217.0K | 100.0% | $-38.5M | $-16.5M | $— | — |
| Q2 null | $221.0K | 100.0% | $-39.7M | $-16.6M | $— | — |
| Q1 null | $230.0K | 100.0% | $-41.4M | $-16.7M | $— | — |
| Q4 null | $76.0K | 100.0% | $-51.6M | $-21.3M | $— | — |
| FY null | $76.0K | 100.0% | $-183.7M | $-61.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-49.0M | $-17.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-43.1M | $-12.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-40.1M | $-9.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-24.2M | $-5.7M | $-0.10 | — |